310 related articles for article (PubMed ID: 26681546)
21. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
[TBL] [Abstract][Full Text] [Related]
22. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation.
Valcavi R; Piana S; Bortolan GS; Lai R; Barbieri V; Negro R
Thyroid; 2013 Dec; 23(12):1578-82. PubMed ID: 23978269
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
[TBL] [Abstract][Full Text] [Related]
25. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
[TBL] [Abstract][Full Text] [Related]
26. Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma.
Kwak JY; Kim EK; Chung WY; Moon HJ; Kim MJ; Choi JR
Radiology; 2009 Dec; 253(3):854-60. PubMed ID: 19710001
[TBL] [Abstract][Full Text] [Related]
27. Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases.
Hong YR; Yan CX; Mo GQ; Luo ZY; Zhang Y; Wang Y; Huang PT
Sci Rep; 2015 Jan; 5():7748. PubMed ID: 25582862
[TBL] [Abstract][Full Text] [Related]
28. Repeat Ultrasound-Guided Fine-Needle Aspiration for Thyroid Nodules 10 mm or Larger Can Be Performed 10.7 Months After Initial Nondiagnostic Results.
Moon HJ; Kim EK; Kwak JY; Yoon JH
AJR Am J Roentgenol; 2016 Apr; 206(4):823-8. PubMed ID: 26959760
[TBL] [Abstract][Full Text] [Related]
29. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
[TBL] [Abstract][Full Text] [Related]
30. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.
Zhao Q; Ming J; Liu C; Shi L; Xu X; Nie X; Huang T
Ann Surg Oncol; 2013 Mar; 20(3):746-52. PubMed ID: 22972508
[TBL] [Abstract][Full Text] [Related]
31. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma.
Lim DJ; Baek KH; Lee YS; Park WC; Kim MK; Kang MI; Jeon HM; Lee JM; Yun-Cha B; Lee KW; Son HY; Kang SK
Thyroid; 2007 Sep; 17(9):883-8. PubMed ID: 17956162
[TBL] [Abstract][Full Text] [Related]
32. Visually discernible [18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: a potential new risk factor.
Yun M; Noh TW; Cho A; Choi YJ; Hong SW; Park CS; Lee JD; Kim CK
J Clin Endocrinol Metab; 2010 Jul; 95(7):3182-8. PubMed ID: 20427505
[TBL] [Abstract][Full Text] [Related]
33. The significance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fine needle aspiration cytology.
Ersoz S; Sert H; Yandi M; Erem C; Mungan S; Ersoz HO; Cobanoglu U; Hacihasanoglu A
Pathol Oncol Res; 2008 Dec; 14(4):457-60. PubMed ID: 18415710
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis and treatment of thyroid microcarcinoma].
Feng J; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1911-7. PubMed ID: 25895303
[TBL] [Abstract][Full Text] [Related]
35. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
[TBL] [Abstract][Full Text] [Related]
36. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
37. Clinical and molecular features of progressive papillary thyroid microcarcinoma.
Wang Z; Ji X; Zhang H; Sun W
Int J Surg; 2024 Apr; 110(4):2313-2322. PubMed ID: 38241301
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
[TBL] [Abstract][Full Text] [Related]
39. Papillary thyroid microcarcinoma: a surgical perspective.
Sakorafas GH; Giotakis J; Stafyla V
Cancer Treat Rev; 2005 Oct; 31(6):423-38. PubMed ID: 16005155
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size.
Lee KJ; Cho YJ; Kim SJ; Lee SC; Kim JG; Ahn CJ; Lee DH
World J Surg; 2011 Feb; 35(2):318-23. PubMed ID: 21153817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]